The DOI matches its Crossref record; 323 of the 326 references it cites were found in a registry or an index.
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020
Open accessAbstract
Eye health and vision have widespread and profound implications for many aspects of life, health, sustainable development, and the economy.Yet nowadays, many people, families, and populations continue to suffer the consequences of poor access to high-quality, affordable eye care, leading to vision impairment and blindness.In 2020, an estimated 596 million people had distance vision impairment worldwide, of whom 43 million were blind.Another 510 million people had uncorrected near vision impairment, simply because of not having reading spectacles.A large proportion of those affected (90%), live in low-income and middle-income countries (LMICs).However, encouragingly, more than 90% of people with vision impairment have a preventable or treatable cause with existing highly cost-effective interventions.Eye conditions affect all stages of life, with young children and older people being particularly affected.Crucially, women, rural populations, and ethnic minority groups are more likely to have vision impairment, and this pervasive inequality needs to be addressed.By 2050, population ageing, growth, and urbanisation might lead to an estimated 895 million people with distance vision impairment, of whom 61 million will be blind.Action to prioritise eye health is needed now.This Commission defines eye health as maximised vision, ocular health, and functional ability, thereby contributing to overall health and wellbeing, social inclusion, and quality of life.Eye health is essential to achieve many of the Sustainable Development Goals (SDGs).Poor eye health and impaired vision have a negative effect on quality of life and restrict equitable access to and achievement in education and the workplace.Vision loss has substantial financial implications for affected individuals, families, and communities.Although high-quality data for global economic estimates are scarce, particularly for LMICs, conservative assessments based on the latest prevalence figures for 2020 suggest that annual global productivity loss from vision impairment is approximately US$410•7 billion purchasing power parity.Vision impairment reduces mobility, affects mental wellbeing, exacerbates risk of dementia, increases likelihood of falls and road traffic crashes, increases the need for social care, and ultimately leads to higher mortality rates.By contrast, vision facilitates many daily life activities, enables better educational outcomes, and increases work productivity, reducing inequality.An increasing amount of evidence shows the potential for vision to advance the SDGs, by contributing towards poverty reduction, zero hunger, good health and wellbeing, quality education, gender equality, and decent work.Eye health is a global public priority, transforming lives in both poor and wealthy communities.Therefore, eye health needs to be reframed as a development as well as a health issue and given greater prominence within the global development and health agendas.Vision loss has many causes that require promotional, preventive, treatment, and rehabilitative interventions.Cataract, uncorrected refractive error, glaucoma, agerelated macular degeneration, and diabetic retinopathy www.thelancet.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures























Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Artificial intelligence (AI) is an accurate screening tool for diabetic retinopathy (DR), the leading cause of blindness among working-aged adults.”
From Referral uptake after diabetic retinopathy screening with artificial intelligence-assisted care pathways: a systematic review and meta-analysis (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Underfunding, alongside scarcity of ophthalmological services and trained personnel, infrastructures are common challenges faced by LMICs, which often delay diagnosis and management, increasing the risk of irreversible vision loss [6].”
From Diabetic retinopathy screening model in low and middle-income countries: a scoping review (2025) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Diabetic retinopathy (DR) is the leading cause of blindness among working-aged adults and early detection is critical for timely management to prevent vision loss1,2.”
From Referral uptake after diabetic retinopathy screening with artificial intelligence-assisted care pathways: a systematic review and meta-analysis (2026) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“The magnitude of diabetes and its sequelae including DR require large-scale screening to enable early intervention, as described in the recent Lancet Global Health Commission on Global Eye Health and contemporary modelling of diabetes prevalence worldwide1,4.”
From Referral uptake after diabetic retinopathy screening with artificial intelligence-assisted care pathways: a systematic review and meta-analysis (2026) · cites this paper as [1]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This capability is crucial for creating VPs that accurately simulate real patients for educational purposes39,40.”
From A large language model digital patient system enhances ophthalmology history taking skills (2025) · cites this paper as [39]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
Transforming Our World: The 2030 Agenda for Sustainable Development
(2018) · A New Era in Global Health · doi:10.1891/9780826190123.ap02 · Cited by 19,351
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Self-citationThe number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,394
Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040
Tham, Y.-C., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C.-Y. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.013 · Cited by 7,159
Self-citation(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050
Holden, B. A., Fricke, T. R., Wilson, D. A., Jong, M., Naidoo, K. S., Sankaridurg, P., Wong, T. Y., Naduvilath, T. J., & Resnikoff, S. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.006 · Cited by 5,500
Self-citation
Research works printed but not linked: 1
- Soleimani-Sefat, 2016, The needs and problems of students with visual impairment, J Soc Sci Hum Stud, 2, 8
Cited by
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 322
Blindness and Vision Impairment
Etya’ale, D. (2023) · Sustainable Development Goals Series · doi:10.1007/978-3-031-33851-9_31 · Cited by 296
Integrated image-based deep learning and language models for primary diabetes care
Li, J., Guan, Z., Wang, J., Cheung, C. Y., Zheng, Y., Lim, L.-L., Lim, C. C., Ruamviboonsuk, P., Raman, R., Corsino, L., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03139-8 · Cited by 250
Self-citationGlobal economic productivity losses from vision impairment and blindness
Marques, A. P., Ramke, J., Cairns, J., Butt, T., Zhang, J. H., Muirhead, D., Jones, I., Tong, B. A. M. A., Swenor, B. K., Faal, H., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100852 · Cited by 236
Self-citationGregg, E. W., Buckley, J., Ali, M. K., Davies, J., Flood, D., Mehta, R., Griffiths, B., Lim, L.-L., Manne-Goehler, J., Pearson-Stuttard, J., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00001-6 · Cited by 232
Metadata
- Authors
- Burton, M. J., Ramke, J., Marques, A. P., Bourne, R. R. A., Congdon, N., Jones, I., Ah Tong, B. A. M., Arunga, S., Bachani, D., Bascaran, C., Bastawrous, A., Blanchet, K., Braithwaite, T., Buchan, J. C., Cairns, J., Cama, A., Chagunda, M., Chuluunkhuu, C., Cooper, A., Crofts-Lawrence, J., Dean, W. H., Denniston, A. K., Ehrlich, J. R., Emerson, P. M., Evans, J. R., Frick, K. D., Friedman, D. S., Furtado, J. M., Gichangi, M. M., Gichuhi, S., Gilbert, S. S., Gurung, R., Habtamu, E., Holland, P., Jonas, J. B., Keane, P. A., Keay, L., Khanna, R. C., Khaw, P. T., Kuper, H., Kyari, F., Lansingh, V. C., Mactaggart, I., Mafwiri, M. M., Mathenge, W., McCormick, I., Morjaria, P., Mowatt, L., Muirhead, D., Murthy, G. V. S., Mwangi, N., Patel, D. B., Peto, T., Qureshi, B. M., Salomão, S. R., Sarah, V., Shilio, B. R., Solomon, A. W., Swenor, B. K., Taylor, H. R., Wang, N., Webson, A., West, S. K., Wong, T. Y., Wormald, R., Yasmin, S., Yusufu, M., Silva, J. C., Resnikoff, S., Ravilla, T., Gilbert, C. E., Foster, A., & Faal, H. B.
- Affiliations
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- University of Auckland (NZ)
- University of Cambridge (GB)
- Queen's University Belfast (GB)
- Sightsavers (GB)
- Mbarara University of Science and Technology (UG)
- Ministry of Health and Family Welfare (IN)
- London School of Hygiene & Tropical Medicine (GB)
- University of Geneva (CH)
- St Thomas' Hospital (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Ministry of Health (MZ)
- National Museum of Mongolia (MN)
- International Agency for the Prevention of Blindness (GB)
- University of Cape Town (ZA)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- University of Michigan (US)
- Emory University (US)
- Johns Hopkins University (US)
- Massachusetts Eye and Ear Infirmary (US)
- Universidade de São Paulo (BR)
- Ministry of Health (KE)
- University of Nairobi (KE)
- Seva Foundation (US)
- Tilganga Institute of Ophthalmology (NP)
- Heidelberg University (DE)
- UNSW Sydney (AU)
- L V Prasad Eye Institute (IN)
- Instituto Mexicano de Oftalmología IAP (MX)
- Muhimbili University of Health and Allied Sciences (TZ)
- University of the West Indies (JM)
- The University of Melbourne (AU)
- Kenya Medical Training College (KE)
- Christoffel Blinden Mission (DE)
- Universidade Federal de São Paulo (BR)
- Fred Hollows Foundation (AU)
- Ministry of Health, Community Development, Gender, Elderly and Children (TZ)
- World Health Organization (CH)
- Beijing Tongren Hospital (CN)
- United Nations (US)
- National University of Singapore (SG)
- World Health Organization Regional Office for the Americas (US)
- Brien Holden Vision Institute (AU)
- Aravind Eye Hospital (IN)
- University of Calabar (NG)
- Corresponding author
- Burton, Matthew J
- ORCID
- Burton, Matthew J
- Ramke, Jacqueline
- Bourne, Rupert R A
- Congdon, Nathan
- Jones, Iain
- Arunga, Simon
- Bachani, Damodar
- Bastawrous, Andrew
- Blanchet, Karl
- Braithwaite, Tasanee
- Buchan, John C
- Cairns, John
- Cama, Anasaini
- Chuluunkhuu, Chimgee
- Dean, William H
- Denniston, Alastair K
- Ehrlich, Joshua R
- Emerson, Paul M
- Evans, Jennifer R
- Frick, Kevin D
- Friedman, David S
- Furtado, João M
- Gichangi, Michael M
- Gichuhi, Stephen
- Gilbert, Suzanne S
- Gurung, Reeta
- Habtamu, Esmael
- Holland, Peter
- Jonas, Jost B
- Keane, Pearse A
- Keay, Lisa
- Khanna, Rohit C
- Khaw, Peng Tee
- Kuper, Hannah
- Kyari, Fatima
- Lansingh, Van C
- Mactaggart, Islay
- Mafwiri, Milka M
- Mathenge, Wanjiku
- McCormick, Ian
- Morjaria, Priya
- Mowatt, Lizette
- Murthy, Gudlavalleti V S
- Mwangi, Nyawira
- Patel, Daksha B
- Salomão, Solange R
- Sarah, Virginia
- Solomon, Anthony W
- Swenor, Bonnielin K
- Taylor, Hugh R
- West, Sheila K
- Wong, Tien Yin
- Wormald, Richard
- Yusufu, Mayinuer
- Silva, Juan Carlos
- Resnikoff, Serge
- Ravilla, Thulasiraj
- Gilbert, Clare E
- Foster, Allen
- Faal, Hannah B
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 9
- Issue
- 4
- Pages
- e489-e551
- ISSN
- 2214-109X (ISSN-L)
- PMC
- PMC7966694
- OpenAlex
- W3130938027
- Cited by
- 1,624
- References
- 326
- Citations by year
- 2026: 335 · 2025: 375 · 2024: 339 · 2023: 263 · 2022: 219 · 2021: 92
- FWCI
- 34.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Global Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, cc-by)
- Research Portal (Queen's University Belfast) (publishedVersion, cc-by)
- Anglia Ruskin Research Online (Anglia Ruskin University) (submittedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion, public-domain)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Reforms
- Keywords
- eye health, visual impairment, blindness, access to eye care, low- and middle-income countries, Sustainable Development Goals, productivity loss, population aging, rural population, ethnic minorities, quality of life, social inclusion, health equity, eye health policy, eye health workforce
- MeSH terms
- Global Burden of Disease, Sustainable Development, Blindness, Eye Diseases, Health Services Accessibility, Humans, Quality of Health Care, Quality of Life, Global Health, Cost of Illness, Advisory Committees
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. https://app.cochat.ai/papers/10.1016/s2214-109x(20)30488-5
- The paper
- Burton, M. J., Ramke, J., Marques, A. P., Bourne, R. R. A., Congdon, N., Jones, I., Ah Tong, B. A. M., Arunga, S., Bachani, D., Bascaran, C., Bastawrous, A., Blanchet, K., Braithwaite, T., Buchan, J. C., Cairns, J., Cama, A., Chagunda, M., Chuluunkhuu, C., Cooper, A., . . . Faal, H. B. (2021). The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. The Lancet Global Health. https://doi.org/10.1016/s2214-109x(20)30488-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.